ASO Visual Abstract: A National Assessment of T2 Staging for Intrahepatic Cholangiocarcinoma and the Poor Prognosis Associated with Multifocality Kevin M. TurnerAaron M. DelmanGregory C. Wilson ASO Visual Abstract 02 May 2022 Pages: 5105 - 5106
Letter to Editor of Annals of Surgical Oncology Concerning “Early Diagnosis of Anastomotic Leakage after Gastric Cancer Surgery via Analysis of Inflammatory Factors in Abdominal Drainage” Fabio CarboniMario Valle Gastrointestinal Oncology 16 March 2022 Pages: 5107 - 5108
Impact of Body Mass Index on Surgical Outcomes in Oncologic Microvascular Head and Neck Reconstruction Malke AsaadChristopher YaoEdward I. Chang Head and Neck Oncology 24 March 2022 Pages: 5109 - 5121
ASO Visual Abstract: Impact of Body Mass Index on Surgical Outcomes in Oncologic Microvascular Head and Neck Reconstruction Malke AsaadChristopher YaoEdward I. Chang ASO Visual Abstract 30 March 2022 Pages: 5122 - 5123
Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck Amanda E. YungGareth CrouchSydney Ch’ng Head and Neck Oncology Open access 13 April 2022 Pages: 5124 - 5138
ASO Author Reflections: Surgery for pT3 and pT4 Cutaneous Squamous Cell Carcinomas of the Head and Neck Provides Robust Outcomes Against Which Emerging Treatment Modalities Should be Compared to Determine Their Role in the Standard of Care Amanda E. YungSydney Ch’ng ASO Author Reflections Open access 07 April 2022 Pages: 5139 - 5140
ASO Visual Abstract: Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck Amanda E. YungGareth CrouchSydney Ch’ng ASO Visual Abstract 06 May 2022 Pages: 5141 - 5142
Correction to: Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: Head and Neck Cancer Anirudh SaraswathulaChristine G. GourinPeter S. Vosler Correction 13 April 2022 Pages: 5143 - 5143
Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma Mengchao WeiManxia LinMing Kuang Hepatobiliary Tumors 19 March 2022 Pages: 5144 - 5153
ASO Author Reflections: Intertumor Biological Heterogeneity Counts in Treatment Selection of Single ≤ 5 cm Hepatocellular Carcinoma Mengchao WeiManxia LinMing Kuang ASO Author Reflections 03 April 2022 Pages: 5154 - 5155
Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection Meredith C. MasonMaciej KrasnodebskiHop S. Tran Cao Hepatobiliary Tumors 10 April 2022 Pages: 5156 - 5164
ASO Visual Abstract: Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection Meredith C. MasonMaciej KrasnodebskiHop S. Tran Cao ASO Visual Abstract 18 April 2022 Pages: 5165 - 5166
Gallbladder Cancer: A Single-Institution 10-Year Experience—Analysis of Adenocarcinoma Subtypes and Tumors Arising from Intracholecystic Papillary Neoplasms Yael BergerBrianne J. SullivanNoah A. Cohen Hepatobiliary Tumors 18 April 2022 Pages: 5167 - 5175
ASO Visual Abstract: Gallbladder Cancer: A Single-Institution 10-Year Experience—Analysis of Adenocarcinoma Subtypes and Tumors Arising From Intracholecystic Papillary Neoplasms Yael BergerBrianne J. SullivanNoah A. Cohen ASO Visual Abstract 20 May 2022 Pages: 5176 - 5176
Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma Alessandro ParoDjhenne DalmacyTimothy M. Pawlik Hepatobiliary Tumors 19 April 2022 Pages: 5177 - 5185
ASO Author Reflections: Association of County-level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment Among Patients with Hepatocellular Carcinoma Alessandro ParoTimothy M. Pawlik ASO Author Reflections 13 April 2022 Pages: 5186 - 5187
ASO Visual Abstract: Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment Among Patients with Hepatocellular Carcinoma Alessandro ParoDjhenne DalmacyTimothy M. Pawlik ASO Visual Abstract 09 May 2022 Pages: 5188 - 5188
Hepatic Resection Combined with Intraoperative Radiofrequency Ablation Versus Hepatic Resection Alone for Selected Patients with Moderately Advanced Multifocal Hepatocellular Carcinomas Kejie ZhengAnque LiaoLi Jiang Hepatobiliary Tumors 19 April 2022 Pages: 5189 - 5201
ASO Author Reflections: How to Choose the Optimal Strategy to Treat Patients with Moderately Advanced Multifocal Hepatocellular Carcinomas? Jinli ZhengHaiding LongHong Wu ASO Author Reflections 16 April 2022 Pages: 5202 - 5203
ASO Visual Abstract: Hepatic Resection Combined With Intraoperative Radiofrequency Ablation Versus Hepatic Resection Alone for Selected Patients With Moderately Advanced Multifocal Hepatocellular Carcinomas Kejie ZhengAnque LiaoLi Jiang ASO Visual Abstract 12 May 2022 Pages: 5204 - 5205
Correction to: Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis Lan-Qing YaoZheng-Liang ChenTian Yang Correction 16 April 2022 Pages: 5206 - 5206
Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort Richard J. Straker IIIKatharine KruppGiorgos C. Karakousis Melanoma 17 March 2022 Pages: 5207 - 5216
ASO Author Reflections: Prognostic Significance of Primary Tumor Infiltrating Lymphocytes in the Contemporary Melanoma Era Richard J. Straker IIIKatharine KruppGiorgos C. Karakousis ASO Author Reflections 18 March 2022 Pages: 5217 - 5218
ASO Visual Abstract: Prognostic Significance of Primary-Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort Richard J. Straker IIIKatharine KruppGiorgos C. Karakousis ASO Visual Abstract 22 March 2022 Pages: 5219 - 5220
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal ChuanLiang CuiBin LianJun Guo Melanoma 09 April 2022 Pages: 5221 - 5234
ASO Author Reflections: Staging System for Mucosal Melanoma: A Proposal to Fill a Gap ChuanLiang CuiBin LianJun Guo ASO Author Reflections 12 April 2022 Pages: 5235 - 5236
ASO Visual Abstract: An Evidence-Based Staging System for Mucosal Melanoma: a Proposal ChuanLiang CuiBin LianJun Guo ASO Visual Abstract 17 May 2022 Pages: 5237 - 5238
Comments on Post-Publication Discussion of “Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma” Robert W. CookMatthew S. Goldberg Melanoma Open access 05 April 2022 Pages: 5239 - 5240
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC) Alexander C. J. van AkkooiTina J. HiekenInternational Neoadjuvant Melanoma Consortium (INMC) Correction 15 April 2022 Pages: 5241 - 5242
Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study Abdelkader TaibiOlivia SgarburaOlivier Glehen Peritoneal Surface Malignancy 22 March 2022 Pages: 5243 - 5251
ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases? Abdelkader TaibiMartin HübnerOlivia Sgarbura ASO Author Reflections 30 March 2022 Pages: 5252 - 5253
ASO Visual Abstract: Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy with or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study Abdelkader TaibiOlivia SgarburaOlivier Glehen ASO Visual Abstract 06 April 2022 Pages: 5254 - 5255
In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival Ibrahim SaidInge UbinkPhilip R. de Reuver Peritoneal Surface Malignancy Open access 16 April 2022 Pages: 5256 - 5262
ASO Visual Abstract: In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is Not a Prognostic Marker for Survival Ibrahim SaidInge UbinkPhilip R. de Reuver ASO Visual Abstract 06 May 2022 Pages: 5263 - 5264
Correction: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Marco TonelloDario BarattiAntonio Sommariva Correction 05 April 2022 Pages: 5265 - 5265
Matched Preliminary Analysis of Patient-Reported Outcomes following Autologous and Implant-Based Breast Reconstruction Jonas A. NelsonMeghana G. ShamsunderRobert J. Allen Jr Reconstructive Oncology 03 April 2022 Pages: 5266 - 5275
ASO Author Reflections: Deeper Understanding of Patient-Reported Outcomes in Breast Reconstruction Patients Not Requiring Radiation Therapy: Harnessing Propensity Matching Methodology Jonas A. NelsonRobert J. Allen Jr. ASO Author Reflections 06 May 2022 Pages: 5276 - 5277
A Matched Preliminary Analysis of Patient-Reported Outcomes After Autologous and Implant-Based Breast Reconstruction Jonas A. NelsonMeghana G. ShamsunderRobert J. Allen Jr. ASO Visual Abstract 03 April 2022 Pages: 5278 - 5279
BREAST-Q REACT: Clinical Reference Values for the BREAST-Q in Post-mastectomy Breast Reconstruction Patients Jonas A. NelsonJacqueline J. ChuBabak J. Mehrara Reconstructive Oncology 12 April 2022 Pages: 5280 - 5293
ASO Author Reflections: Patient-Reported Outcomes for Breast Reconstruction Clinical Practice Jacqueline J. ChuJonas A. Nelson ASO Author Reflections 18 March 2022 Pages: 5294 - 5295
ASO Visual Abstract: BREAST-Q REACT—Clinical Reference Values for the BREAST-Q in Post-mastectomy Breast Reconstruction Patients Jonas A. NelsonJacqueline J. ChuBabak J. Mehrara ASO Visual Abstract 30 March 2022 Pages: 5296 - 5296
Construction and Verification of Risk Predicting Models to Evaluate the Possibility of Venous Thromboembolism After Robot-Assisted Radical Prostatectomy Xu ChengLizhi ZhouYinhuai Wang Urologic Oncology Open access 22 March 2022 Pages: 5297 - 5306
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy Keiichiro MoriVictor M. SchuettfortEuropean Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU) Urologic Oncology Open access 26 March 2022 Pages: 5307 - 5316
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder? Keiichiro MoriVictor M. SchuettfortShahrokh F. Shariat ASO Author Reflections Open access 12 April 2022 Pages: 5317 - 5318
ASO Visual Abstract: Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy Keiichiro MoriVictor M. SchuettfortEuropean Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU) ASO Visual Abstract 09 May 2022 Pages: 5319 - 5320
Effect of Papaverine on Renal Artery Blood Flow during Robot-Assisted Partial Nephrectomy: A Randomized Controlled Study Jihion YuJun-Young ParkYoung-Kug Kim Urologic Oncology 03 April 2022 Pages: 5321 - 5329
ASO Author Reflections: Papaverine and Beneficial Renal Effects in Robot-Assisted Partial Nephrectomy Jihion YuCheryn SongYoung-Kug Kim ASO Author Reflections 26 March 2022 Pages: 5330 - 5331
ASO Visual Abstract: Effect of Papaverine on Renal Artery Blood Flow During Robot-Assisted Partial Nephrectomy Jihion YuJun-Young ParkYoung-Kug Kim ASO Visual Abstract 06 April 2022 Pages: 5332 - 5332
Utility of Postoperative Serial Renal Function Monitoring in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma Christopher BitconStewart WhalenRoss Mason Urologic Oncology 05 April 2022 Pages: 5333 - 5337
ASO Visual Abstract: Examining the Utility of Postoperative Serial Renal Function Monitoring in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma Christopher BitconStewart WhalenRoss Mason ASO Visual Abstract 12 May 2022 Pages: 5338 - 5339